Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab
Koen Zwart, Sietske C. van Nassau, Frederieke H. van der Baan, Miriam Koopman, Pétur Snæbjörnsson, Anna J. van Gestel, Geraldine R. Vink, Jeanine M.L. Roodhart
Topics & Concepts
CetuximabColorectal cancerMedicineOncologyInternal medicinePopulationCancerEnvironmental healthColorectal Cancer Treatments and StudiesMelanoma and MAPK PathwaysLung Cancer Treatments and Mutations